Skip to main content
Published locations for Delaying second dose of SARS-CoV-2 vaccine not advisable in IBD patients treated with infliximab
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Delaying second dose of SARS-CoV-2 vaccine not advisable in IBD patients treated with infliximab
User login
Username
Password
Reset your password
/content/delaying-second-dose-sars-cov-2-vaccine-not-advisable-ibd-patients-treated-infliximab
/gihepnews/article/241588/ibd-intestinal-disorders/delaying-second-dose-sars-cov-2-vaccine-not